Why is RNA Down Today?
About Avidity Biosciences, Inc. Common Stock
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -1.8%
Market Comparison
🔔 Get RNA Alerts
We'll notify you when RNA's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
RNA has moved more than 3.0% down on 24 occasions in the past year.
Frequently Asked Questions
Why is RNA stock down today?
This appears to be a sector-wide move. The PHARMACEUTICAL PREPARATIONS sector is down 1.8% on average.
Is RNA stock a buy or sell right now?
Based on current analysis, RNA shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the RNA stock price target?
RNA is currently trading at $8.10. Based on today's momentum, the expected short-term range is $7.85 - $8.26. See long-term price prediction →
Will RNA stock continue falling?
Our analysis shows a 45% probability that RNA's move continues in the next 1-3 days. Key level to watch: $7.69 (support).
Is RNA stock oversold or overbought?
RNA's RSI (Relative Strength Index) is currently at 25.1. This indicates oversold conditions - the stock may be due for a bounce as selling pressure appears exhausted.
What is the momentum for RNA stock?
RNA's 10-day momentum indicator is at -1.42. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is RNA outperforming or underperforming the market?
RNA (-2.23%) is currently significantly underperforming the market (-2.4% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.
What does MACD indicate for RNA?
RNA's MACD (-1.14) is currently below the signal line (-1.06), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 44.9) is strong.
Is RNA in an uptrend or downtrend?
Based on moving average analysis, RNA is in a bearish trend. The price ($8.10) is trading below both the 20-day SMA ($9.81) and 50-day SMA ($11.48). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis